SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020
Open Access
- 4 June 2020
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 25 (22), 2-7
- https://doi.org/10.2807/1560-7917.ES.2020.25.22.2001010
Abstract
End of April 2020, French clinicians observed an increase in cases presenting with paediatric inflammatory multisystem syndrome (PIMS). Nationwide surveillance was set up and demonstrated temporospatial association with the coronavirus disease (COVID-19) epidemic for 156 reported cases as at 17 May: 108 were classified as confirmed (n = 79), probable (n = 16) or possible (n = 13) post-COVID-19 PIMS cases. A continuum of clinical features from Kawasaki-like disease to myocarditis was observed, requiring intensive care in 67% of cases.This publication has 9 references indexed in Scilit:
- Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 PandemicCirculation, 2020
- Guillain-Barre Syndrome Associated with SARS-CoV-2The New England Journal of Medicine, 2020
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 InfectionCell, 2020
- An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort studyThe Lancet, 2020
- Hyperinflammatory shock in children during COVID-19 pandemicThe Lancet, 2020
- Type I IFN immunoprofiling in COVID-19 patientsJournal of Allergy and Clinical Immunology, 2020
- Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki diseaseEuropean Journal of Clinical Investigation, 2020
- Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2017
- Concurrent Respiratory Viruses and Kawasaki DiseasePEDIATRICS, 2015